Activity of the CCAAT-enhancer-binding TF CEBPB in glia cells has been previously shown to be directly enhanced by the presence of Aβ (Ramberg et al., 2011; Yao et al., 1833-1852), suggesting a direct link between AD pathology and CLU upregulation. The gene discussed is CEBPB; the disease is Alzheimer disease.